Posted inLondon Stock Exchange
OptiBiotix reports strong revenue growth and expands global footprint in 2024
LONDON: OptiBiotix Health plc (AIM: OPTI), a UK-based life sciences company focused on microbiome modulation and healthy sugar alternatives, reported a 35% increase in annual revenue for the year ending…